Central Pharmaceutical No3 Balance Sheet Health
Financial Health criteria checks 6/6
Central Pharmaceutical No3 has a total shareholder equity of ₫490.5B and total debt of ₫4.6B, which brings its debt-to-equity ratio to 0.9%. Its total assets and total liabilities are ₫566.9B and ₫76.3B respectively. Central Pharmaceutical No3's EBIT is ₫135.5B making its interest coverage ratio -7.3. It has cash and short-term investments of ₫295.8B.
Key information
0.9%
Debt to equity ratio
₫4.63b
Debt
Interest coverage ratio | -7.3x |
Cash | ₫295.84b |
Equity | ₫490.51b |
Total liabilities | ₫76.35b |
Total assets | ₫566.86b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: DP3's short term assets (₫383.1B) exceed its short term liabilities (₫75.4B).
Long Term Liabilities: DP3's short term assets (₫383.1B) exceed its long term liabilities (₫975.0M).
Debt to Equity History and Analysis
Debt Level: DP3 has more cash than its total debt.
Reducing Debt: DP3's debt to equity ratio has reduced from 5.9% to 0.9% over the past 5 years.
Debt Coverage: DP3's debt is well covered by operating cash flow (2782.5%).
Interest Coverage: DP3 earns more interest than it pays, so coverage of interest payments is not a concern.